US6555692B1
(en)
*
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
SE9601318D0
(sv)
*
|
1996-04-04 |
1996-04-04 |
Pharmacia Biosensor Ab |
Method for nucleic acid analysis
|
US6251591B1
(en)
*
|
1997-02-27 |
2001-06-26 |
Lorne Park Research, Inc. |
Quantitative method for detecting nucleotide concentration
|
US6046004A
(en)
*
|
1997-02-27 |
2000-04-04 |
Lorne Park Research, Inc. |
Solution hybridization of nucleic acids with antisense probes having modified backbones
|
US6355421B1
(en)
|
1997-10-27 |
2002-03-12 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to PNA molecular beacons
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
US6361942B1
(en)
|
1998-03-24 |
2002-03-26 |
Boston Probes, Inc. |
Method, kits and compositions pertaining to detection complexes
|
US6403313B1
(en)
*
|
1999-12-21 |
2002-06-11 |
Ingeneus Corporation |
Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators
|
US6656692B2
(en)
*
|
1999-12-21 |
2003-12-02 |
Ingeneus Corporation |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
US6294333B1
(en)
|
1998-12-31 |
2001-09-25 |
Ingeneus Corp. |
Fluorescent intensity assay for protein or peptide binding to nucleic acids
|
US6420115B1
(en)
|
1999-12-21 |
2002-07-16 |
Ingeneus Corporation |
Cation mediated triplex hybridization assay
|
US6858390B2
(en)
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
PT1471926E
(pt)
|
1999-06-01 |
2011-03-11 |
Baylor College Medicine |
Composições e métodos para a utilização terapêutica de uma sequência associada a atonal
|
AU5882000A
(en)
|
1999-06-22 |
2001-01-09 |
Invitrogen Corporation |
Improved primers and methods for the detection and discrimination of nucleic acids
|
US6645733B1
(en)
|
1999-06-25 |
2003-11-11 |
Ingeneus Corporation |
Fluorescent intensity method for assaying binding between proteins or peptides
|
US6830902B1
(en)
|
1999-07-02 |
2004-12-14 |
Invitrogen Corporation |
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
|
WO2001038585A2
(en)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
|
US7309569B2
(en)
|
1999-12-21 |
2007-12-18 |
Ingeneus, Inc. |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
US20030181412A1
(en)
*
|
1999-12-21 |
2003-09-25 |
Ingeneus Corporation |
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
|
US6927027B2
(en)
|
1999-12-21 |
2005-08-09 |
Ingeneus Corporation |
Nucleic acid multiplex formation
|
US7052844B2
(en)
*
|
1999-12-21 |
2006-05-30 |
Ingeneus, Inc. |
Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism
|
US6924108B2
(en)
*
|
1999-12-21 |
2005-08-02 |
Ingeneus Corporation |
Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues
|
US6911536B1
(en)
|
1999-12-21 |
2005-06-28 |
Ingeneus Corporation |
Triplex and quadruplex catalytic hybridization
|
US6982147B2
(en)
*
|
2000-01-24 |
2006-01-03 |
Ingeneus Corporation |
Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions
|
US6613524B1
(en)
|
2000-01-24 |
2003-09-02 |
Ingeneus Corporation |
Amperometric affinity assay and electrically stimulated complexes of nucleic acids
|
US7220541B2
(en)
|
2000-01-24 |
2007-05-22 |
Ingeneus, Inc. |
Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
|
US20030170659A1
(en)
*
|
2000-01-24 |
2003-09-11 |
Ingeneus Corporation |
Electrical treatment of binding media to encourage, discourage and/or study biopolymer binding
|
US6265170B1
(en)
|
2000-01-24 |
2001-07-24 |
Ingeneus Corporation |
Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
|
EP1294939B1
(en)
*
|
2000-04-03 |
2010-01-27 |
Cytyc Corporation |
Detection and typing of human papillomavirus using pna probes
|
US6936443B2
(en)
*
|
2000-04-03 |
2005-08-30 |
Cytyc Corporation |
Detection and typing of human papillomavirus using PNA probes
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
US20030165859A1
(en)
*
|
2001-10-23 |
2003-09-04 |
Invitrogen Corporation |
Primers and methods for the detection and discrimination of nucleic acids
|
DE10155031A1
(de)
*
|
2001-11-09 |
2003-05-28 |
Friz Biochem Gmbh |
Fluoreszenz-Quenchen zur Detektion von Ligat-Ligand Assoziationsereignissen in elektrischen Feldern
|
EP1572902B1
(en)
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP2221377B2
(en)
|
2002-02-01 |
2017-05-17 |
Life Technologies Corporation |
Oligonucleotide compositions with enhanced efficiency
|
US6818420B2
(en)
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
CA2494844C
(en)
|
2002-08-12 |
2013-10-15 |
David Kirn |
Methods and compositions concerning poxviruses and cancer
|
US20040180345A1
(en)
*
|
2003-03-14 |
2004-09-16 |
Ingeneus Corporation |
Pre-incubation method to improve signal/noise ratio of nucleic acid assays
|
AU2005284822B2
(en)
|
2004-09-14 |
2011-03-24 |
Regents Of The University Of Colorado |
Method for treatment with bucindolol based on genetic targeting
|
WO2006033088A2
(en)
*
|
2004-09-24 |
2006-03-30 |
Ingeneus Inc. |
Genomic assay
|
JP2006254784A
(ja)
*
|
2005-03-17 |
2006-09-28 |
Institute Of Physical & Chemical Research |
プライマーダイマーからの非特異的増幅を減少させる方法
|
JP2009507853A
(ja)
|
2005-09-07 |
2009-02-26 |
ジェンネレックス インコーポレイティッド |
Gm−csf発現ポックスウイルスを用いる転移性および/または全身播種性癌の全身処置
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
ATE378427T1
(de)
*
|
2005-10-17 |
2007-11-15 |
Rina Netzwerk Rna Technologien |
Verfahren zur bestimmung einer unbekannten pns seqenz und seine verwendungen
|
ES2551892T3
(es)
|
2006-09-15 |
2015-11-24 |
Ottawa Health Research Institute |
Rhabdovirus oncolítico
|
US8929630B2
(en)
|
2009-03-27 |
2015-01-06 |
Life Technologies Corporation |
Systems and methods for assessing images
|
WO2011008530A2
(en)
|
2009-06-29 |
2011-01-20 |
Luminex Corporation |
Chimeric primers with hairpin conformations and methods of using same
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
WO2011032180A1
(en)
|
2009-09-14 |
2011-03-17 |
Jennerex, Inc. |
Oncolytic vaccinia virus combination cancer therapy
|
MX365946B
(es)
|
2009-12-10 |
2019-06-19 |
Turnstone Lp |
Rabdovirus oncolitico.
|
DK2515899T3
(en)
|
2009-12-23 |
2016-08-15 |
Arca Biopharma Inc |
METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
|
US9919047B2
(en)
|
2011-01-04 |
2018-03-20 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
CA2828532A1
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
|
AU2012226530B2
(en)
|
2011-03-08 |
2016-12-01 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
WO2012167382A1
(en)
|
2011-06-08 |
2012-12-13 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
RU2483049C2
(ru)
*
|
2011-07-21 |
2013-05-27 |
Открытое акционерное общество "Научно-исследовательский институт полимерных материалов" |
Способ изготовления партии многошашечных зарядов твердого ракетного топлива
|
US10040853B2
(en)
|
2011-09-09 |
2018-08-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving NKG2D inhibitors and cancer
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
AU2014221143B2
(en)
|
2013-02-21 |
2019-02-07 |
Turnstone Limited Partnership |
Vaccine composition
|
MX2016004283A
(es)
|
2013-10-03 |
2016-10-12 |
Oklahoma Med Res Found |
Biomarcadores para la actividad, e intesidad y arrebato de la enfermedad lupus eritematoso sistemico.
|
EP3224362B1
(en)
|
2014-11-26 |
2024-09-25 |
The Regents of The University of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
CA2998886C
(en)
|
2015-09-16 |
2023-05-16 |
PetaOmics, Inc. |
Methods and compositions for genomic target enrichment and selective dna sequencing
|
CN110462062A
(zh)
|
2017-01-26 |
2019-11-15 |
俄克拉荷马医学研究基金会 |
系统性红斑狼疮疾病活动性、强度和急性发作的生物标志物
|
US12140592B2
(en)
|
2017-06-16 |
2024-11-12 |
Oklahoma Medical Research Foundation |
Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
|
WO2020081204A1
(en)
|
2018-10-18 |
2020-04-23 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
AU2019371161A1
(en)
|
2018-10-31 |
2021-06-17 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Biomarkers and methods of use for radiation-induced lung injury
|
WO2021055489A1
(en)
|
2019-09-16 |
2021-03-25 |
Grohar Patrick J |
Compositions and methods for the treatment of swi-snf mutant tumors
|